相关实验视频

Updated: Sep 15, 2025

Use of Interferon-γ Enzyme-linked Immunospot Assay to Characterize Novel T-cell Epitopes of Human Papillomavirus

Use of Interferon-γ Enzyme-linked Immunospot Assay to Characterize Novel T-cell Epitopes of Human Papillomavirus

Published on: March 8, 2012

在患有多发性硬化症的女性患者中,HPV基因型的患病率和分布

Mojtaba Shahbazi¹, Maryam Kaeedi², Sanaz Heydari Havadaragh¹

¹Iranian Center of Neurological Research, Neuroscience Institute, Tehran University of Medical Sciences, Tehran, Iran.

Multiple sclerosis and related disorders

|July 15, 2025

概括

这项研究发现,与健康个体相比,在接受多发性硬化症 (MS) 治疗的女性中,人类乳头瘤病毒 (HPV) 感染或变异基因型的风险没有增加. 需要进一步的研究来证实这些发现,并探索HPV疫苗接种对MS患者的益处.

科学领域:

免疫学免疫学免疫学
神经学神经学
传染性疾病传染性疾病

背景情况:

多发性硬化症 (MS) 是一种慢性自身免疫性中枢神经系统疾病.
对MS的疾病修饰疗法 (DMT) 可能会增加感染风险,包括人类乳头瘤病毒 (HPV).
在接受治疗的多发性硬化症患者中调查HPV患病率和基因型至关重要.

研究的目的:

为了比较免疫调节疗法治疗的女性多发性硬化患者的HPV患病率和基因型分布,与健康对照组进行比较.
评估HPV感染与MS特征或治疗状态之间的潜在关联.

主要方法:

对50名患有多发性硬化症的女性和50名匹配健康对照 (年龄在18-45岁) 的横截面研究.
数据收集包括人口统计,病史,MS细节和HPV风险因素.
使用聚合酶链反应 (PCR) 分析HPV DNA的宫拭片.

主要成果:

在MS患者中,HPV患病率为22.0%,在对照组中为16.0%,没有统计学上显著的差异 (P=0.444).
两组之间没有观察到HPV基因型分布的显著变化.
阳性HPV多发性硬化症患者年轻;在基线特征,病程或治疗中没有发现其他显著差异.

结论:

在接受免疫抑制疗法和健康对照组的女性多发性硬化患者之间,HPV患病率或基因型分布没有显著差异.
建议进行更大规模的长期研究,以澄清HPV-MS关系和HPV疫苗接种的潜在益处.
未来的研究应该考虑HPV和MS的地理和种族差异.

关键词:

一个女人,一个女人.人类乳头瘤病毒人类乳头瘤病毒.多发性硬化症是多发性硬化症.流行程度流行程度

更多相关视频

A Comparative Approach to Characterize the Landscape of Host-Pathogen Protein-Protein Interactions

A Comparative Approach to Characterize the Landscape of Host-Pathogen Protein-Protein Interactions

Published on: July 18, 2013

Author Spotlight: Creating a Versatile Experimental Autoimmune Encephalomyelitis Model Relevant for Both Male and Female Mice

Author Spotlight: Creating a Versatile Experimental Autoimmune Encephalomyelitis Model Relevant for Both Male and Female Mice

Published on: October 13, 2023

相关概念视频

Prevalence and Incidence

Prevalence and Incidence

In statistical epidemiology and health sciences, two essential metrics—prevalence and incidence—are fundamental for understanding disease dynamics within a population. These measures enable public health officials, epidemiologists, and researchers to assess the burden of diseases, allocate resources effectively, and design impactful public health policies and interventions.
Prevalence indicates the proportion of individuals in a population who have a specific disease or health...

Disorders of the Female Reproductive System

Disorders of the Female Reproductive System

The female reproductive system can be affected by several disorders, including Premenstrual Syndrome (PMS), Premenstrual Dysphoric Disorder (PMDD), endometriosis, and various forms of cancer. PMS and PMDD are cyclical conditions that cause physical and emotional distress, with symptoms that include edema, mood swings, and food cravings. PMDD is a more severe form of PMS characterized by increased symptom severity that peaks during the luteal phase and tends to improve or resolve shortly after...

Rous Sarcoma Virus (RSV) and Cancer

Rous Sarcoma Virus (RSV) and Cancer

Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...